Lyudmila Vladimirovna Olkhova

Lyudmila Vladimirovna Olkhova

Auto-generated profile, based on publicly available information

Lyudmila Vladimirovna Olkhova

Russian Children’s Clinical Hospital – Branch of the N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Педиатрический вестник Южного Урала
Verified
Journal Article
Closed access
ОЖО.г. Желудкова
О.г. Желудкова
ЛОЛ.в. Ольхова
Л.в. Ольхова
Экстраневральные метастазы (ЭНМ) первичных опухолей центральной нервной системы встречаются крайне редко. В литературе описаны единичные клинические случаи, либо небольшие серии случаев, но этот патогенез и причины развития ЭНМ в настоящее время остаются недостаточно ясными. Целью данного обзора является лучшее понимание факторов риска развития ЭНМ, возникших после шунтирования. Выполнен литературный поиск с использованием основных баз данных, произведен анализ ЭНМ по различным клиническим критериям. Наиболее часто шунт-ассоциированные ЭНМ по данным литературы развиваются при герминомах, медуллобластомах и глиобластомах. Использование вентрикулоатриальных шунтов максимально часто ассоциировалось с более ранним метастатическим поражением костной системы и лимфатических узлов и меньшими сроками выживаемости по сравнению с другими типами шунтирующих систем. При выполнении шунтирующих оперативных вмешательств необходимо динамическое наблюдение за пациентами с целью более раннего выявления возможных ЭНМ. С учетом частоты развития шунт-ассоциированных метастазов, ликворошунтирующие операции, особенно у пациентов с высокоагрессивными опухолями, должны использоваться в качестве коррекции гидроцефалии по строгим показаниям, основным из которых является гипорезорбтивная гидроцефалия после удаления опухоли. Альтернативой шунтированию также можно считать эндоскопическую тривентрикулостомию, которая может скорректировать опухоль-ассоциированную обструктивную гидроцефалию без риска развития шунт-ассоциированных ЭНМ или других шунт-ассоциированных осложнений. Extraneural neural metastases (ENMs) of primary tumors of the central nervous system are extremely rare. Single clinical cases or a small series of cases are described in the literature, but this pathogenesis and causes of the development of ENM are currently not clear enough. The purpose of this review is to better understand the risk factors for developing ENM that have arisen after shunting. A literature search was performed using the main databases, an analysis of the ENM was performed according to various clinical criteria. Most often, shunt-associated ENMs according to the literature develop with germinomas, medulloblastomas and glioblastomas. The use of ventriculoatrial shunts was most often associated with an earlier metastatic lesion of the skeletal system and lymph nodes and shorter survival times compared to other types of shunt systems. When performing shunting surgical interventions, dynamic monitoring of patients is necessary in order to earlier identify possible ENMs. Given the frequency of development of shunt-associated metastases, liquor-guiding surgery, especially in patients with highly aggressive tumors, should be used as a correction of hydrocephalus according to strict indications, the main of which is hyporesorbing hydrocephalus after removal of the tumor. An alternative to shunting is endoscopic triventriculostomy, which can correct tumor-associated obstructive hydrocephalus without the risk of developing shunt-associated ENMs or other shunt-associated complications.

21 May 2021 in Pediatric Hematology/Oncology and Immunopathology
Verified
Journal Article
Open access
PDF file
LOL. V. Olkhova
L. V. Olkhova
OZO. G. Zheludkova
O. G. Zheludkova
LZL. S. Zubarovskaya
L. S. Zubarovskaya
ASA. Yu. Smirnova
A. Yu. Smirnova
YDYu. V. Dinikina
Yu. V. Dinikina
ТСТ. Ю. Скворцова
Т. Ю. Скворцова
Atypical teratoid/rhabdoid tumor (AT/RT) of the central nervous system (CNS) is an aggressive malignant tumor that is mainly found in younger children and is associated with poor prognosis. Our objectives: to present the results of treatment of children with CNS AT/RT under 3 years of age and assess the impact of various prognostic factors on patient survival. The study was approved by the Independent Ethics Committee and the Scientific Council of the N.I. Pirogov Russian National Research Medical University of Ministry of Healthcare of the Russian Federation. The study included 106 patients with CNS AT/RT aged 0–3 years who had been treated and monitored from 2008 to 2020. The median age was 16 (9; 23) months. All the patients underwent primary tumor resection with subsequent chemotherapy according to various protocols. At the time of the analysis, 47 patients (44.4%) were alive, 1 patient (0.9%) was lost to follow-up and 58 patients (54.7%) were dead, of whom 52 patients (90%) had died of disease progression and 6 (10%) – of polychemotherapy complications. One patient developed shunt-related intraabdominal metastasis within 10 months of the diagnosis. The 1-year progression-free survival (PFS) was 0.50; the 2-year PFS was 0.29; the 5-year PFS – 0.27. The median PFS was 12 months. The 1-year overall survival (OS) was 0.72; the 2-year OS was 0.53; the 5-year OS – 0.40. The median OS was 27 months. An analysis of patients with CNS AT/RT under 3 years of age showed that PFS was statistically significantly higher in: children aged 12 months; children with totally resected tumours; children who had received polychemotherapy in accordance with the ATRT-2006 protocol that included radiotherapy and regional administration of a triplet of chemotherapeutic agents. The OS in patients with CNS AT/RT aged 3 years was statistically significantly higher in: children aged 12 months; children who had been treated with radiation therapy; patients who had received cytosar/etoposide intrathecally/intraventricularly; patients who had undergone high-dose chemotherapy with subsequent autologous hematopoietic stem cell transplantation. A multivariate analysis revealed that PFS was influenced by age, tumor location, extent of resection and exposure to radiation therapy, regional chemotherapy or high-dose chemotherapy with autologous hematopoietic stem cell transplantation, while OS was affected by age and exposure to radiation therapy.

3 July 2024 in Journal of Modern Oncology
Verified
Journal Article
Open access
PDF file
YDYulia V. Dinikina
Yulia V. Dinikina
OZOlga G. Zheludkova
Olga G. Zheludkova
MRMarina V. Ryzhova
Marina V. Ryzhova
LOLiudmila V. Olhova
Liudmila V. Olhova
DKDenis Yu. Korneev
Denis Yu. Korneev
MBMargarita B. Belogurova
Margarita B. Belogurova
Metronomic chemotherapy (MCT) is a promising direction of anticancer therapy, as well as in pediatric oncology, and its administration in patients with refractory and recurrent tumors of the central nervous system becomes increasingly relevant. Being a regimen of low doses of antitumor agents with different mechanisms of action in a continuous mode for a long time, it allows to overcome the resistance of tumor cells and to minimize the toxic effects of treatment. Today, the issues of rational choice of MCT regimens, which are dependent on the type of tumor, and the application of biomarkers of its effectiveness, remain controversial. The article discusses in detail the biological effects of MCT with an accent on antiangiogenic one, as well as the possibilities and limitations of MCT application in pediatric practice and the results of studies in tumors of the central nervous system.

7 April 2021 in Russian Journal of Pediatric Hematology and Oncology
Verified
Journal Article
Open access
PDF file
AMA. V. Mezentseva
A. V. Mezentseva
LOL. V. Olkhova
L. V. Olkhova
EME. B. Machneva
E. B. Machneva
VKV. V. Konstantinova
V. V. Konstantinova
ABA. E. Burya
A. E. Burya
ESE. V. Skorobogatova
E. V. Skorobogatova
Relevance. Infectious septic complications caused by polyresistant gram-negative micro-organisms are a pressing issue in the treatment of patients after polychemotherapy (PCT) and hematopoietic stem cell transplantation at the high risk of the fulminant current and high lethality against the background of hematopoesis aplasia. One of the therapeutic strategies of antimicrobial treatment is the systematic use of 0.5 % hydroxymethylquinoxaline dioxide (dioxidine) solution in the complex antibacterial therapy of patients with severe infectious-septic complications. The preparation has a bactericidal type of action, a wide spectrum of antibacterial activity. Experience in adult clinical practice has demonstrated the effectiveness of dioxidine in the treatment of the most severe forms of aerobic and anaerobic infection. Strict dose enforcement and injection technique to avoid the appearance of side effects. Data on the intravenous use of dioxin in children are presented in a limited number of scientific literature.The aim of the study was to demonstrate the efficacy of systemic use of hydroxymethylquinoxaline dioxide (0.5 % dioxidine solution) in children with infectious complications progressing against the background of aplasia of hematopoiesis caused by multidrug-resistant pathogens Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterobacter cloacae, Stenotrophomonas maltophilia.Materials and methods. 16 patients with a verified gram-negative infection were prescribed 0.5 % hydroxymethylquinoxaline dioxide solution as part of a combination antimicrobial therapy were included in the retrospective study. The median age of patients was 5 years (6 months – 16 years), 11 (69 %) were boys and 5 (31 %) girls.All children included in the study has infectious-septic complications at the PCT-induced hematopoietic aplasia, obtained according to the protocols of the main disease: severe combined immune deficiency (n = 2), idiopathic aplastic anaemia (n = 3), solid tumor (n = 2), acute myeloblastic leukemia (n = 7), acute lymphoblastic leukemia (n = 2). The main criterion for adding to the study was the existence at the least one site with a verified gram-negative infection (Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterobacter cloacae, Stenotrophomonas maltophilia): bacteriemia (n = 11), oral mucosa (n = 6), ulcerative necrotic damage of perineum (n = 6), enterocolite (n = 6), infectionseptic compartments in the subcutaneous fat (n = 4), pleuropneumonia (n = 4), abscesses and inflammatory infiltration of the liver, spleen, pancreas, kidneys, lymph nodes (n = 1), infection of soft tissues in the area of the ventricular bypass with inflammatory changes of the brain membranes (n = 1).All patients received 0.5 % of the solution of dioxin by injection according of vital importance, as they had pathogens with confirmed laboratory resistance or clinical progression of the infectious process against the background of combined antibacterial therapy.Discussion. There is a complete control of fulminant developing infectious-septic processes caused by polyresistant micro-organisms against the background of hydroxymethylquinoxaline dioxide therapy in all 16 patients. The eradication of the pathogen, according to the microbiological study, has been confirmed in almost all observed patients, the efficacy of the drug has been preserved throughout the period of treatment, and the resistance of micro-organisms has not been observed. Strict adherence to the dosing and infusion technique of hydroxymethylquinoxaline dioxide has helped to achieve the full resolution of the infection process in all children without side-effects.Conclusion. On the basis of the experience presented, in immunocomputed patients of young age, 0.5 % dioxidine solution can be used as a necessary reserve preparation for the treatment of the most severe forms of infections of different localization, caused by polyresistant strains of gram-negative micro-organisms.

14 January 2026 in Russian Journal of Pediatric Hematology and Oncology
Verified
Journal Article
Open access
PDF file
LOL. V. Olkhova
L. V. Olkhova
ESE. V. Skorobogatova
E. V. Skorobogatova
This article describes the only case of unstable hemoglobin Calgary in Russia in a two-year-old Russian boy with severe transfusiondependent anemia caused by a de novo point mutation in the β-globin gene (HBB: c.194G>T). The combination of the clinical picture of severe anemia, occurring as a major form of β-thalassemia, with the absence of specific laboratory signs complicated the diagnostic search, which was completed only thanks to modern molecular genetic methods. Currently, the only radical method of treating transfusion-dependent hemoglobinopathies is allogeneic hematopoietic stem cell transplantation. A literature review is presented demonstrating general information about the disease, international literature data on allogeneic hematopoietic stem cell transplantation for unstable hemoglobinopathies, as well as our own experience of successful use of this method. The patient's parents have given consent for the use of information, including photographs of the child, in scientific research and publications.

21 April 2021 in Pediatric Hematology/Oncology and Immunopathology
Verified
Journal Article
Open access
PDF file
EME. B. Machneva
E. B. Machneva
AMA. V. Mezentseva
A. V. Mezentseva
LOL. V. Olkhova
L. V. Olkhova
EPE. A. Pristanskova
E. A. Pristanskova
ABA. E. Burya
A. E. Burya
ESE. V. Skorobogatova
E. V. Skorobogatova
BCG (Bacillus Calmette–Guérin) vaccine is widely used for the vaccination of newborns within the first few days of life to prevent mycobacterial infections. However, complications occurring after BCG vaccination in patients with primary immunodeficiencies (PIDs) can lead to serious consequences for their health and life. BCG vaccine-related complications occurring in patients with severe combined immunodeficiency (SCID) and chronic granulomatous disease (CGD) after hematopoietic stem cell transplantation (HSCT) constitute an important problem. The article presents a retrospective observational analysis of 45 patients with SCID and CGD who received BCG vaccination and underwent HSCT. In the post-transplant period, 33 (73.3%) patients had BCG-related complications, either localized or generalized. The presence of BCG vaccine-related complications in the pre-transplant period was a significant predictor of the development of post-transplant complications. The most severe and long-term BCG vaccine-related complications were observed in the patients with SCID: the median time to the resolution of symptoms of BCG infection was 30 days and 100 days in the CGD patients and the SCID patients, respectively (p 0.001). The severity of BCG vaccine-related complications, the nature of the primary disease and the presence of pre-transplant BCG vaccine-related complications did not affect the overall survival (OS) of the patients: OS for the entire study group was 79.5 ± 6.6%. Non-compliance with antimycobacterial prophylaxis prior to HSCT resulted in severe infections in a number of patients. The treatment of BCG vaccine-related complications included a combination of several antimycobacterial agents, and anti-inflammatory drugs (such as glucocorticoids, interleukin-1 and 6 receptor antagonists) in cases of immune reconstitution inflammatory syndrome (n= 18). The only effective method of prophylaxis of BCG-related infections in patients with SCID and CGD in the pre- and post-transplant period is the exemption of newborns from BCG vaccination based on their family history. Uninterrupted antimycobacterial prophylaxis in vaccinated patients in the pre- and post-transplant period is also important. Furthermore, an effective uniform strategy for the prevention and treatment of BCG vaccine-related complications in PID patients both before and after HSCT is needed.